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Background. We have investigated the changes in absolute myocardial blood flow (AMF) after intracoronary injections of mesenchymal SC (MSC) 
and compared to controls in closed-chest reperfused acute myocardial infarction (AMI) in pigs.
Methods. Female farm pigs were subjected to 90-min occlusion of the left anterior descending coronary artery (LAD) followed by reperfusion. 
Allogeneic male pig MSCs were transiently transfected with Luciferase (Luc-MSC) and delivered (9.7±1.2x10^6) intracoronary into the open LAD 
(infarct-related artery) one-week post-AMI in female pigs (group MSC, n=10), while saline was injected with the same injection rate in controls 
(group C, n=10). The AMF was measured by pressure wire immediately after, and 3, 12 and 24h post-intracoronary Luc-MSC or saline injections. 
In vitro bioluminescence images were performed for visualization of the Luc-MSC location and distribution. Quantitative real-time TaqMan PCR 
measurements were done to quantify the sex-mismatched MSCs.
Results. No difference between the groups was observed regarding the weight, heart rate, blood pressure and global ejection fraction (38±5% vs 
37±6% in group MSC and C) 1-week post-AMI. The baseline AMF were similar in the groups (61.3±15. vs 61.1±12.0 ml/min). AMF was decreased 
significantly immediately after intracoronary MSC delivery (42.0±12.4 vs 57.7±15.7 ml/min p=0.013), and remained low at 3h (40.9±13.4 vs 
55.8±4.9 ml/min, p=0.004), 12h (43.0±3.7 vs 57.8±5.4 ml/min, p=0.001) with incomplete recovery at 24h (47.2±5.5 vs 62.1±14.1 ml/min, 
p=0.038) as compared to controls, respectively. Fluorescent microscopy displayed entrapment of the MSCs in the arterioles and capillaries. In vitro 
bioluminescence displayed transfected Luc-MSCs along the proximal and mid part of the LAD, with limited number (295±101 sry copied/million 
cardiac cells) of Y-chromosome-MSCs in the infarcted area.
Conclusions. Intracoronary injection of SCs results in immediate decrease of AMF, with delayed recovery. The delivery of the SC into the injured 
myocardium might be hindered by the altered coronary pressure and flow conditions.
